CLINICAL RESEARCH
Prevalence and impact of fibromyalgia on disease activity in a sample of Iraqi patients with rheumatoid arthritis
1
Rheumatology Unit, College Of medicine, University of Baghdad, Baghdad, Iraq
2
Rheumatology Unit, Baghdad Teaching Hospital, Baghdad, Iraq
Submission date: 2021-06-14
Acceptance date: 2021-08-03
Publication date: 2021-10-04
Arch Med Sci Civil Dis 2021;6(1):125-131
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disease. Fibromyalgia (FM) is a common diffuse pain syndrome in several rheumatic diseases. This study aimed to find the prevalence of FM in RA patients and to explore its impact on the disease activity of RA patients.
Material and methods:
A total of 170 RA patients diagnosed according to the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for RA were enrolled in this cross-sectional study. Age, gender, body mass index, marital status, educational level, occupation, smoking history, disease duration, and medications used were reported. Fibromyalgia was diagnosed by using the fibromyalgia criteria 2016 revision. The disease activity of RA patients was measured by using the clinical disease activity index (CDAI) and disease activity score-28 (DAS28).
Results:
The mean age of fibromyalgia syndrome (FMS) patients was 51.263 ±11.531 years, and for non-FMS patients it was 48.469 ±13.932 years. FM was present in 57 (42.7%) RA patients, among whom the prevalence of FMS among female patients was 36.4%, which was significantly higher than that among male patients, at 6.3% (p = 0.015). FM significantly increased the disease activity measured by DAS28 ( = 0.241, p = 0.001) and by CDAI ( = 0.359, p < 0.001). Female gender and functional class of patients with RA positively increase the disease activity DAS28 ( = 0.142, p = 0.032; = 0.396, p > 0.001), while only functional class increased the disease activity measured by CDAI ( = 0.373, p > 0.001).
Conclusions:
The occurrence of FM in RA patients was common, and there was significant positive correlation between FMS severity and RA disease activity.
Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disease. Fibromyalgia (FM) is a common diffuse pain syndrome in several rheumatic diseases. This study aimed to find the prevalence of FM in RA patients and to explore its impact on the disease activity of RA patients.
Material and methods:
A total of 170 RA patients diagnosed according to the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for RA were enrolled in this cross-sectional study. Age, gender, body mass index, marital status, educational level, occupation, smoking history, disease duration, and medications used were reported. Fibromyalgia was diagnosed by using the fibromyalgia criteria 2016 revision. The disease activity of RA patients was measured by using the clinical disease activity index (CDAI) and disease activity score-28 (DAS28).
Results:
The mean age of fibromyalgia syndrome (FMS) patients was 51.263 ±11.531 years, and for non-FMS patients it was 48.469 ±13.932 years. FM was present in 57 (42.7%) RA patients, among whom the prevalence of FMS among female patients was 36.4%, which was significantly higher than that among male patients, at 6.3% (p = 0.015). FM significantly increased the disease activity measured by DAS28 ( = 0.241, p = 0.001) and by CDAI ( = 0.359, p < 0.001). Female gender and functional class of patients with RA positively increase the disease activity DAS28 ( = 0.142, p = 0.032; = 0.396, p > 0.001), while only functional class increased the disease activity measured by CDAI ( = 0.373, p > 0.001).
Conclusions:
The occurrence of FM in RA patients was common, and there was significant positive correlation between FMS severity and RA disease activity.
REFERENCES (24)
1.
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
3.
Centola M, Cavet G, Shen Y, et al. Development of a multi-biomarker disease activity test for rheumatoid arthritis. PLoS One 2013; 8: e60635.
4.
Solomon DH, Reed GW, Kremer JM, et al. Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol 2015; 67: 1449-55.
5.
Zernikow B, Gerhold K, Bürk G, et al. Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Schmerz 2012; 26: 318.
6.
Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology 2018; 57: 1453-60.
7.
Joharatnam N, McWilliams DF, Wilson D, et al. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Therapy 2015; 17: 11.
8.
Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012; 2012: 584573.
9.
Lee YC, Lu B, Boire G, et al. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Ann Rheum Dis 2013; 72: 949-54.
10.
Haliloglu S, Carlioglu A, Akdeniz D, et al. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 2014; 34: 1275-80.
11.
Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaboration initiative. Arthritis Rheum 2010; 62: 2569-81.
12.
World Health Organization. Obesity: preventing and managing the global epidemic. World Health Organization 2000; 894(i–xii): 1-253.
13.
Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016; 46: 319-29.
14.
Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology 2010; 49: 924-8.
15.
Ranzolin A, Brenol JCT, Bredemeier M, et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, Health Assessment Questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 2009; 61: 794-800.
16.
Wolfe F, Michaud K. Severe rheumatoid arthritis, worse outcomes, comorbid illness and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 2004; 31: 695-700.
17.
Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol 2019; 17: 101423.
18.
Ton E, Bakker MF, Verstappen S, et al. Look beyond the DAS28: tender points influence the DAS28 in patients with rheumatoid arthritis. J Rheumatol 2012; 39: 22-7.
19.
Ranzolin A, Brenol JC, Bredemeier M, et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 2009; 61: 794-800.
20.
Vilaseca DR, Otero CH. Effect of the coexistence of fibromyalgia in the DAS28 index in women with rheumatoid arthritis. Rheumatol Clin 2008; 40: 96-9.
21.
Rehman AU, Rasheed A, Wagan AA, et al. impact of fibromyalgia on Das-28 score in rheumatoid arthritis. Pakistan Armed Forces Med J 2018; 68: 1210-4.
22.
Coury F, Rossat A, Tebib A, et al. Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol 2009; 36: 58-62.
23.
Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int 2017; 37: 1527-39.
24.
Arnold LM, Clauw DJ, McCarberg BH. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011; 86: 457-64.
| ISSN: | 2451-0637 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
